Considering the long prodromal DPR accumulation accompanied by subtle brain atrophy in C9orf72 patients (Proudfoot et al, 2014; Rohrer et al, 2015; Edbauer & Haass, 2016), mutation carriers may require very early treatment as proposed for Alzheimer's disease. Here, C9orf72 is linked to Alzheimer disease.